Unknown

Dataset Information

Confined placental mosaicism and the association with pregnancy outcome and fetal growth: a review of the literature.


ABSTRACT:

Background

Chromosomal mosaicism can be detected in different stages of early life: in cleavage stage embryos, in blastocysts and biopsied cells from blastocysts during preimplantation genetic testing for aneuploidies (PGT-A) and later during prenatal testing, as well as after birth in cord blood. Mosaicism at all different stages can be associated with adverse pregnancy outcomes. There is an onward discussion about whether blastocysts diagnosed as chromosomally mosaic by PGT-A should be considered safe for transfer. An accurate diagnosis of mosaicism remains technically challenging and the fate of abnormal cells within an embryo remains largely unknown. However, if aneuploid cells persist in the extraembryonic tissues, they can give rise to confined placental mosaicism (CPM). Non-

SUBMITTER: Eggenhuizen GM 

PROVIDER: S-EPMC8382909 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature